Relapse Rate and MRI Activity in Young Adult Patients With Multiple Sclerosis: A Post Hoc Analysis of Phase 3 Fingolimod Trials

Multiple Sclerosis Journal - Experimental, Translational and Clinical
doi 10.1177/2055217318778610
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients With Relapsing–Remitting Multiple Sclerosis: Pooled Analysis From the FREEDOMS/FREEDOMS II Trials

Neurology and Therapy
Neurology
2019English

Correction To: Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients With Relapsing–Remitting Multiple Sclerosis: Pooled Analysis From the FREEDOMS/FREEDOMSII Trials

Neurology and Therapy
Neurology
2020English

Peripheral Blood T Cell Dynamics Predict Relapse in Multiple Sclerosis Patients on Fingolimod

PLoS ONE
Multidisciplinary
2015English

PND14 Characteristics of Multiple Sclerosis Patients With High Relapse Rate Using a Claims Database

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Severe CD4 Lymphocytopenia in Patients With Multiple Sclerosis Treated With Fingolimod

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Seasonal Variations of 25-Oh Vitamin D Serum Levels in Multiple Sclerosis Patients With Relapse Using MRI

European Journal of Translational Myology
OrthopedicsNeurologySports MedicineCell BiologyMolecular Biology
2019English

Relapse in Multiple Sclerosis

British Medical Journal
Medicine
2015English

Cryptococcal Meningoencephalitis Treated With Fingolimod in a Patient With Multiple Sclerosis

Turkiye Klinikleri Journal of Case Reports
2019English

Primary Cutaneous Cryptococcus in a Patient With Multiple Sclerosis Treated With Fingolimod

JAMA Neurology
Neurology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy